Nature Nanotechnology publishes RIVM research on plastics On Thursday 20 January, Nature Nanotechnology published the article Quantitative tracing of uptake and transport of submicrometre plastics in crop plants using lanthanide chelates as a dual-functional tracer.
RIVM study confirms: Tata Steel site is main source of PAHs and metals in the IJmond region A new study conducted by RIVM shows that the PAHs and metals present in the living environment of residents of the IJmond region predominantly originate from the Tata Steel site.
Quality of protective equipment insufficient during COVID-19 crisis The personal protective equipment (PPE) purchased at the national level during the COVID-19 crisis for use in the healthcare sector only partly met the required standards of quality.
200 thousand people tested positive in one week 201,536 positive COVID-19 tests were reported to RIVM last week. That is an increase of 77% compared to the previous week. Such high numbers of reported infections within just one week have never been seen before in the Netherlands.
Omicron causes 35% increase in positive COVID-19 tests, despite lockdown In the past week*, the number of reported positive COVID-19 tests increased by 35% compared to the week before that. The number of people tested by the GGD was about the same.
Largest drop in number of tuberculosis cases in the Netherlands in fifty years Last year, the incidence of tuberculosis (TB) in the Netherlands fell sharply. The 17% drop is the largest in fifty years. In 2020, 623 cases were notified compared to 754 in 2019.
Method for safe and sustainable recycling of waste The method developed by RIVM to assess whether waste treatment is sufficiently safe and sustainable, can contribute to the European ambitions for a safe and more circular economy.
Vaccination with AstraZeneca vaccine will start again The Ministry of Health, Welfare and Sport (VWS) has decided to resume vaccinating with the COVID-19 vaccine made by AstraZeneca within the near future.
First invitations for people aged 75-79 years arriving Saturday Starting tomorrow, the first people in the age group from 75-79 years will receive an invitation from RIVM for a COVID-19 vaccination. These people were born in the years from 1941 through 1946.
Care workers in WMO-based support invited for COVID-19 vaccination As of today, the following groups of care workers will be invited for COVID-19 vaccination in the Netherlands.